Endoscopic submucosal dissection combined with clip for closure of gastrointestinal fistulas including those refractory to previous therapy.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
07 2022
Historique:
aheadofprint: 09 09 2021
pubmed: 10 9 2021
medline: 1 7 2022
entrez: 9 9 2021
Statut: ppublish

Résumé

Gastrointestinal (GI) fistula is a life-threatening condition and a therapeutic challenge. Endoscopic approaches include mucosal abrasion, clip closure, or stent diversion, with moderate success rates in the long term. We assessed whether fistula endoscopic submucosal dissection with clip closure (FESDC) could lead to complete resolution of fistulas even after failure of previous endoscopic therapy. Patients with GI fistulas, including those with previous failed treatment, were retrospectively included. The primary outcome was long-term (> 3 months) success of fistula healing. Secondary outcomes included technical success, safety, and factors associated with FESDC success. 23 patients (13 refractory 57 %) were included. Tight immediate sealing was achieved in 19 patients (83 %; 95 % confidence interval [CI] 61 %-95 %). Long-term closure was achieved in 14 patients (61 %; 95 %CI 39 %-80 %), with median follow-up of 20 months. Complications occurred in two patients (9 %). Previous local malignancy ( This novel FESDC strategy was demonstrated to be safe and feasible for permanent endoscopic closure of GI fistulas. Further studies are warranted to determine the place of this technique in the management of chronic GI fistula.

Sections du résumé

BACKGROUND
Gastrointestinal (GI) fistula is a life-threatening condition and a therapeutic challenge. Endoscopic approaches include mucosal abrasion, clip closure, or stent diversion, with moderate success rates in the long term. We assessed whether fistula endoscopic submucosal dissection with clip closure (FESDC) could lead to complete resolution of fistulas even after failure of previous endoscopic therapy.
METHODS
Patients with GI fistulas, including those with previous failed treatment, were retrospectively included. The primary outcome was long-term (> 3 months) success of fistula healing. Secondary outcomes included technical success, safety, and factors associated with FESDC success.
RESULTS
23 patients (13 refractory 57 %) were included. Tight immediate sealing was achieved in 19 patients (83 %; 95 % confidence interval [CI] 61 %-95 %). Long-term closure was achieved in 14 patients (61 %; 95 %CI 39 %-80 %), with median follow-up of 20 months. Complications occurred in two patients (9 %). Previous local malignancy (
CONCLUSION
This novel FESDC strategy was demonstrated to be safe and feasible for permanent endoscopic closure of GI fistulas. Further studies are warranted to determine the place of this technique in the management of chronic GI fistula.

Identifiants

pubmed: 34500487
doi: 10.1055/a-1641-7938
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

700-705

Commentaires et corrections

Type : CommentIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Pierre Lafeuille (P)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Timothée Wallenhorst (T)

Department of Gastroenterology and Endoscopy, Pontchaillou University Hospital, Rennes, France.

Alexandru Lupu (A)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Jérémie Jacques (J)

Department of Gastroenterology and Endoscopy, Dupuytren University Hospital, Limoges, France.

Thomas Lambin (T)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Marine Camus (M)

Department of Gastroenterology and Endoscopy, Saint Antoine Hospital, Paris, France.

Clara Yzet (C)

Department of Gastroenterology and Endoscopy, Amiens University Hospital, Amiens, France.

Thierry Ponchon (T)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Florian Rostain (F)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Jérôme Rivory (J)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Fabien Subtil (F)

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France.

Mathieu Pioche (M)

Department of Gastroenterology and Endoscopy, Edouard Herriot Hospital, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH